µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
C917 T-¼¼Æ÷ ´ë °ú¸³»ó ¸²ÇÁ±¸¼º ¹éÇ÷º´(·ù¸¶Æ¼½º°üÀý¿° °ü·Ã) T-cell large granular lymphocytic leukaemia(associated with rheumatoid arthritis)
C918 ¼º¼÷ B-¼¼Æ÷¹éÇ÷º´, ¹öŶº´ Mature B-cell leukaemia Burkitt-type
C919 »ó¼¼ºÒ¸íÀÇ ¸²ÇÁ¼º ¹éÇ÷º´ Lymphoid leukemia, unspecified
C92 °ñ¼ö¼º ¹éÇ÷º´ Myeloid leukemia
C92 °ú¸³±¸¼º ¹éÇ÷º´ Granulocytic leukemia
C92 °ñ¼ö¼º ¹éÇ÷º´ Myelogenous leukemia
C920 ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] Acute myeloblastic leukemia[AML]
C9200 t(8:21)À» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ AML with t(8:21)
C9200 AML1/ETO AML1/ETO
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, inv(16)(p13:q22) Acute myeloid leukaemia, inv(16)(p13:q22)
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, t(16:16)(p13:q11) Acute myeloid leukaemia, t(16:16)(p13:q11)
C9201 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, CBF-beta/MYH11 Acute myeloid leukaemia, CBF-beta/MYH11
C9208 ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] Other and inspecigied acute myeloblastic leukaemia [AML]
C9208 ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´, ÃÖ¼ÒºÐÈ­ Acute myeloblastic leukaemia, minimal differentiation
C9208 ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´(¼º¼÷À» µ¿¹ÝÇÑ) Acute myeloblastic leukaemia (with maturation)
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M0 AML M0
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M1 AML M1
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M2 AML M2
C9208 ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ (FABºÐ·ù¸¦ µ¿¹ÝÇÏÁö ¾ÊÀº) NOS AML (without FAB) NOS
C9208 º¯ÇüµÈ ¸ð¼¼Æ÷°úÀ×À» µ¿¹ÝÇÑ ºÒÀÀ¼ººóÇ÷ Refractory anaemia with excess blasts in transformation
171  172  173  174  175  [176] 177  178  179  180